Interleukin-2 and interleukin-4 display potent antitumour activity on rat medullary thyroid carcinoma cells-Reference-Cited by-同舟云学术

Interleukin-2 and interleukin-4 display potent antitumour activity on rat medullary thyroid carcinoma cells

Published:1995-12 Issue:13-14 Volume:31 Page:2379-2384
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cressent M.,Pidoux E.,Cohen R.,Modigliani E.,Roth C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Familial amyloid-producing medullary thyroid carcinoma and pheochromocytoma—a distinct genetic entity;Schimke;Am J Int Med,1965

2. Naturally occurring medullary thyroid carcinoma in the rat;Boorman;Arch Pathol,1972

3. Early spontaneous deficiency of calcitonin renal binding sites in rats with a high incidence of calcitonin-secreting tumours (Wag/Rij);Bouizar;Cancer Res,1987

4. Cancer immunotherapy using interleukin-2 and interleukin-2 activated lymphocytes;Rosenberg;Annu Rev Immunol,1986

5. Interleukin-2 production by tumour cell by-passes T helper function in the generation of antitumour response;Fearon;Cell,1990

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer;Frontiers in Endocrinology;2020-08-07

2. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice;Frontiers in Immunology;2020-06-12

3. Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies;The Journal of Clinical Endocrinology & Metabolism;2013-10

4. Immunotherapy of Neuroendocrine Tumors;Immunoendocrinology in Health and Disease;2004-08-30

5. Antitumor Capacity of a Dominant-NegativeRETProto-Oncogene Mutant in a Medullary Thyroid Carcinoma Model;Human Gene Therapy;2003-07-10